Literature DB >> 6219736

Cytostatic activity on tumour cells of monocytes from patients with gastrointestinal cancer.

B Mytar, M Zembala, W Uracz, A Czupryna.   

Abstract

The ability of monocytes from patients with gastrointestinal cancer to inhibit tumour cell growth and suppress PHA-induced lymphocyte response in vitro was assessed. Isolated monocytes, i.e., adherent Fc+ cells from mononuclear cell suspension, were cytostatic but not cytolytic for both K562 line and L1210 lymphoma cells. Monocytes from the patients showed an increased ability to inhibit the growth of L1210 but not K562 line cells. The increased cytostatic activity of monocytes was associated with their suppressor activity. This suggests that suppressor monocytes are also able to arrest tumour cell growth in vitro.

Entities:  

Mesh:

Year:  1982        PMID: 6219736     DOI: 10.1007/bf00205387

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

1.  Cytolytic and cytostatic activity on tumor cells of circulating human monocytes.

Authors:  A Mantovani; T R Jerrells; J H Dean; R B Herberman
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

2.  Macrophage content of tumours in relation to metastatic spread and host immune reaction.

Authors:  S A Eccles; P Alexander
Journal:  Nature       Date:  1974-08-23       Impact factor: 49.962

3.  Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney sarcoma virus-induced tumors.

Authors:  H Kirchner; R B Herberman; M Glaser; D H Lavrin
Journal:  Cell Immunol       Date:  1974-07       Impact factor: 4.868

4.  Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.

Authors:  M Zembala; B Mytar; T Popiela; G L Asherson
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

5.  Interaction of Bacillus Calmette--Guérin-activated macrophages and neoplastic cells in vitro. I. Conditions of binding and its selectivity.

Authors:  P A Marino; D O Adams
Journal:  Cell Immunol       Date:  1980-08-15       Impact factor: 4.868

6.  Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice.

Authors:  H Kirchner; H T Holden; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

7.  Isolation of human monocytes by rosetting with antibody coated human erythrocytes and isopycnic gradient centrifugation.

Authors:  M Zembala; W Uracz; I Ruggiero; E M Lemmel
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer patients.

Authors:  T R Jerrells; J H Dean; G Richardson; G B Cannon; R B Herberman
Journal:  Int J Cancer       Date:  1979-06-15       Impact factor: 7.396

9.  Cytotoxicity to tumor cells of monocytes from normal individuals and cancer patients.

Authors:  T L Gerrard; J J Terz; A M Kaplan
Journal:  Int J Cancer       Date:  1980-11-15       Impact factor: 7.396

10.  Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.

Authors:  H Kirchner; T M Chused; R B Herberman; H T Holden; D H Lavrin
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  4 in total

1.  Human tumour-induced inhibition of interferon action in vitro: reversal of inhibition by beta-carotene (pro-vitamin A).

Authors:  J Rhodes; P Stokes; P Abrams
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

2.  Serial immunological testing in patients with gastric cancer.

Authors:  M Zembala; T Popiela; D Kowalczyk; B Mytar; A Pituch-Noworolska; I Ruggiero; W Uracz; A Czupryna; H Labza
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  The altered expression of MHC-class II determinants on monocytes of cancer patients.

Authors:  W Uracz; J Stachura; A Pituch-Noworolska; T Popiela; A Czupryna; M Zembala
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Tumour-cell-induced production of tumour necrosis factor by monocytes of gastric cancer patients receiving BCG immunotherapy.

Authors:  M Zembala; A Czupryna; J Wieckiewicz; M Jasinski; J Pryjma; I Ruggiero; M Siedlar; T Popiela
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.